Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-24T18:42:47.315Z Has data issue: false hasContentIssue false
  • English
  • Français

Role of Parenteral Nutrition in Inflammatory Bowel Disease, Acute Renal Failure, and Hepatic Encephalopathy

Clinical Efficacy Assessment Subcommittee of the Health and Public Policy Subcommittee American College of Physicians

Published online by Cambridge University Press:  10 March 2009

Seymour Perry ,
Ruth Hanft  and
Richard Chzanowski
Seymour Perry
Affiliation:
Section Coordinator
Ruth Hanft
Affiliation:
Section Editor
Richard Chzanowski
Affiliation:
Section Editor
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Technology Assessment Reports
Information
International Journal of Technology Assessment in Health Care , Volume 6 , Issue 4 , October 1990 , pp. 655 - 662
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baker, J. P., Detsky, A. S. & O'Rourke, K. Total parenteral nutrition as a primary therapy in inflammatory bowel disease (unpublished).Google Scholar
Naylor, C. D., Detsky, A. S., O'Rourke, K. & Fonberg, E.Does treatment with amino acids and hypertonic glucose improve survival in acute renal failure? A meta-analysis. Renal Failure, 1987, 10, 150–57.CrossRefGoogle ScholarPubMed
Naylor, C. D., O/Rourke, K. & Detsky, A. S.Does parenteral nutrition with branched-chain amino acids improve the clinical outcome of patients with hepatic encephalopathy? A metaanalysis. Gastroenterology, 1989, 97, 1033–42.CrossRefGoogle Scholar
L'Abbe, K. A., Detsky, A. S. & O'Rourke, K.Meta-analysis in clinical research. Annals of Internal Medicine, 1987, 107, 224–33.CrossRefGoogle ScholarPubMed
Fazio, V. W., Kodner, I., Jagelmar, D. G. et al. Inflammatory disease of the bowel: Parenteral nutrition as primary or adjunctive treatment. Diseases of the Colon and Rectum, 1976, 19, 574–78.Google ScholarPubMed
Rombeau, J. L., Barot, L. R., Williamson, L. E. & Mullen, J. L.Preoperative total parenteral nutrition and surgical outcome in patients with inflammatory bowel disease. American Journal of Surgery, 1982, 143, 139–43.CrossRefGoogle ScholarPubMed
Dickinson, R. J., Ashton, M. R., Axon, A. T. R. et al. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology, 1980, 79, 1199–1204.CrossRefGoogle Scholar
McIntyre, P. B., Powell-Tuck, J., Wood, S. R. et al. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut, 1986, 277, 481–84.CrossRefGoogle Scholar
Greenberg, G. R., Fleming, C. R., Jeejeebhoy, K. N. et al. Controlled trial of bowel rest and nutritional support in the management of Crohn's disease, abstracted. Gastroenterology, 1985, 88, 140.Google Scholar
Lochs, H., Meryn, S., Marosi, L. et al. Has total bowel rest a beneficial effect in the treatment of Crohn's disease? Clinical Nutrition, 1983, 2, 61–64.CrossRefGoogle Scholar
Abel, R. M., Beck, C. H. Jr, Abbott, W. M. et al. Improved survival from acute renal failure after treatment with intravenous essential I-amino acids and glucose. New England Journal of Medicine, 1973, 288, 695–99.CrossRefGoogle Scholar
Mirtallo, J. M., Schneider, R. J., Mavko, K. et al. A comparison of essential and general amino acid infusions in the nutritional support of patients with compromised renal function. Journal of Parenteral and Enteral Nutrition, 1982, 6, 109–13.CrossRefGoogle ScholarPubMed
Leonard, C. D., Luke, R. G. & Siegel, R. R.Parenteral essential amino acids in acute renal failure. Urology, 1975, 6, 154–57CrossRefGoogle ScholarPubMed
Feinstein, E. I., Blumenkrantz, M. J., Healey, M. et al. Clinical and metabolic responses to parenteral nutrition in acute renal failure. Medicine, 1981, 60, 124–37.CrossRefGoogle ScholarPubMed
Baek, S.-M., Makabali, G. G., Bryan-Brown, C. W. et al. The influence of parenteral nutrition on the course of acute renal failure. Surgery, Gynecology, and Obstetrics, 1975, 141, 405–08.Google ScholarPubMed
Abel, R. M., Beck, C. H. Jr, Abbott, W. M. et al. Evaluation of renal-failure treatment (letter). New England Journal of Medicine, 1973, 288, 1304.Google Scholar
McPherson, K.Statistics: The problem of examining accumulating data more than once. New England Journal of Medicine, 1974, 290, 501–02.CrossRefGoogle ScholarPubMed
Fischer, J. E. Efficacy of branched chain amino acids in the treatment of hepatic encephalopathy. In Capocaccia, L., Fischer, J. E. & Rossi-Fanelli, F. (eds.), Hepatic encephalopathy in chronic liver failure. New York: Plenum Press, 1984, 311–21.CrossRefGoogle Scholar
Nasrallah, S. M. & Galambos, J. T.Amino acid therapy of alcoholic hepatitis. Lancet, 1980, ii, 1276–77.CrossRefGoogle Scholar
Fischer, J. E. Treatment of hepatic encephalopathy with branched chain amino acids. In Kleinberger, G., Ferenci, P., Riederer, P. & Thaler, H. (eds.), Advances in hepatic encephalopathy and urea cycle diseases. Basel: Karger, 1984, 27–40.Google Scholar
Tgystrup, N. Discussion. In Kleinberger, G., Ferenci, P., Riederer, P. & Thaler, H. (eds.), Advances in hepatic encephalopathy and urea cycle diseases. Basel: Karger, 1984, 46–56.Google Scholar
Koretz, R. L.What supports nutritional support? Digestive Diseases and Sciences, 1984, 29, 577–88.CrossRefGoogle ScholarPubMed
Tygstrup, N. & Vilstrup, H. Effect of branched chain amino acids on the outcome of hepatic encephalopathy. In Kleinberger, G., Ferenci, P., Riederer, P. & Thaler, H. (eds.), Advances in hepatic encephalopathy and urea cycle diseases. Basel: Karger, 1984, 11–14.Google Scholar
Cerra, F. B., Chung, N. K., Fischer, J. E. et al. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind controlled trial. Journal of Parenteral and Enteral Nutrition, 1985, 9, 288–95.CrossRefGoogle ScholarPubMed
Rossi-Fanelli, F., Riggio, Q., Cangiano, C. et al. Branched chain amino acids versus lactulose in the treatment of hepatic coma. A controlled study. Digestive Diseases and Sciences, 1982, 27, 929–35.CrossRefGoogle Scholar
Wahren, J., Denis, J., Desurmont, P. et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology, 1983, 3, 475–80.CrossRefGoogle ScholarPubMed
Michel, H., Pomier-Layrargues, X., Aubin, J. P. et al. Treatment of hepatic encephalopathy by infusion of a modified amino-acid solution: results of a controlled study in 47 cirrhotic patients. In Capocaccia, L., Fischer, J. E. & Rossi-Fanelli, F. (eds.), Hepatic encephalopathy in chronic liver failure. New York: Plenum Press, 1984, 301–10.CrossRefGoogle Scholar
Fiaccadori, F., Ghinelli, F., Pedretti, G. et al. Branched chain amino acid enriched solution in the treatment of hepatic encephalopathy: A controlled trial. In Capocaccia, L., Fischer, J. E. & Rossi-Fanelli, F. (eds.) Hepatic encephalopathy in chronic liver failure. New York: Plenum Press, 1984, 323–33.CrossRefGoogle Scholar
Gluud, C., Dejgaard, A., Hardt, E et al. Preliminary treatment results with balanced amino acid infusion to patients with hepatic encephalopathy (Abstract). Scandinavian Journal of Gastroenterology, 1983, 18 (suppl 86), 19.Google Scholar
Rakette, S., Fischer, M., Reimann, H.-J. & Von, Sommoggy S. Effect of special amino acid solutions in patients with liver cirrhosis and hepatic encephalopathy. In Walser, M. & Williams, J. R. (eds.), Metabolism and clinical implications of branched chain amino acids and ketoacids. Amsterdam: Elsevier North Holland, 1981, 419–25.Google Scholar
Strauss, E., Santos, W. R. & DaSilva, E. C.A randomized controlled clinical trial for the evaluation of the efficacy of an enriched branched chain amino acid solution compared to neomycin in hepatic encephalopathy, abstracted. Hepatology, 1983, 3, 862.Google Scholar
Fiaccadori, F., Ghinelli, F., Pelosi, G. et al. Selective amino acid solutions in hepatic encephalopathy treatment. La Ricerca Clin Lab, 1980, 10, 411–22.CrossRefGoogle ScholarPubMed